Delivery Order SPE2DB20D3303-SPE2DB25FA2BD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,570.81 to AmerisourceBergen Drug Corp for the delivery of 20 DRAM 1-CLIC amber vials. This firm fixed-price, non-set-aside delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine procurement of pharmaceutical packaging materials to support...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $4,216.30 to AmerisourceBergen Drug Corp on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award represents a pharmaceutical delivery to be...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,004.85 to AmerisourceBergen Drug Corp on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor under its broader contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,912.62 to AmerisourceBergen Drug Corp on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $126,953.03 to AmerisourceBergen Drug Corp on July 21, 2025, for pharmaceutical and medical supply deliveries to support federal healthcare operations. This firm fixed price delivery order, which is a child contract under a larger vehicle, carries an ultimate completion date of July 22, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award was made through...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,440.70 to AmerisourceBergen Drug Corp on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The Defense Logistics Agency awarded a $2,262.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical vials (Pro One, 16 Dram amber with reversible caps). The contract was competitively awarded without a set-aside designation and is scheduled for completion by August 1, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $54,074.37 to AmerisourceBergen Drug Corp on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 30, 2025, represents a $1,576.31 firm fixed-price procurement from the Defense Logistics Agency's Medical Supply Chain. The contract is unset-aside and competitively awarded, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of July 31, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,684.19 to AmerisourceBergen Drug Corp on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction for pharmaceutical products and medical supplies. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2BDDelivery Order
The Defense Logistics Agency awarded a $1,638.24 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the procurement of medical vials (40 dram, professional grade, 1 cap stock pack, amber colored). This firm fixed-price, non-set-aside contract is scheduled for completion by August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. This award is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, AmerisourceBergen maintains an extensive portfolio of federal contracts with DLA for medical supplies and pharmaceuticals serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The competitively awarded IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medical commodities across multiple therapeutic domains to support worldwide military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/1/25 |